E-drug: Is Big Pharma the next target for attack? (cont'd)
-------------------------------------------------------------------------
It was an excellent idea of Barbara to put the link to the isomer article
in E-Drug. Actually the only good example I can remember is
labetalol, where the most serious side effects reside in one of the
isomers devoid of adrenergic blocking activity. However, attempts to
market the active isomer failed commercially.
Best wishes,
Leo Offerhaus
Dr.L.Offerhaus
Koedijklaan 1a
NL-1406 KW Bussum
The Netherlands
e-mail: lo@euronet.nl
Phone +31-35-6923288 Fax +31-35-6923277
--
To send a message to E-Drug, write to: e-drug@healthnet.org
To subscribe or unsubscribe, write to: majordomo@healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: e-drug-help@healthnet.org
Information and archives: http://www.essentialdrugs.org/edrug